Skip to main content
editorial
. 2020 Jan 1;27(1):8–10. doi: 10.5551/jat.ED119

Fig. 1.

Fig. 1.

Possible underlying mechanisms of gender difference in ASCVD: estrogen, SIRT1, and eNOS

ASCVD: atherosclerotic cardiovascular disease; Sir1: sirtuin 1; Sir3: sirtuin 3; SERM: selective estrogen receptor modulator; ERAA: estrogen receptor agonist-antagonists; ERα: estrogen receptor α; ERβ: estrogen receptor β; Pcsk9: proprotein convertase subtilisin/kexin family 9; eNOS: endothelial nitric oxide synthase; ROS: reactive oxygen species; SOD: superoxide dismutase.